Pages that link to "Q51450182"
Jump to navigation
Jump to search
The following pages link to Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling. (Q51450182):
Displaying 6 items.
- Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia (Q38714704) (← links)
- Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma. (Q54941924) (← links)
- Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists (Q87656022) (← links)
- Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice (Q87887349) (← links)
- Prevention and treatment of relapse after stem cell transplantation with immunotherapy (Q88797022) (← links)
- Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease (Q91782610) (← links)